Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review
Previous meta-analyses reported discordant results on the efficacy and safety of thrombopoietin receptor agonists (TPO-RA) as second-line treatment in patients with immune thrombocytopenia (ITP). We conducted a meta-analysis of primary ITP treatment with the TPO-RA Romiplostim, Eltrombopag and Avatr...
Main Authors: | Simone Birocchi, Gian Marco Podda, Marco Manzoni, Giovanni Casazza, Marco Cattaneo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-02-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2020.1745168 |
Similar Items
-
Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists
by: Lamya Garabet, et al.
Published: (2020-02-01) -
Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia
by: Jundong Zhang, et al.
Published: (2023-04-01) -
Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis
by: Joyce Tumaini Massaro, et al.
Published: (2019-10-01) -
Thrombocytopenia induced by clopidogrel: a rare adverse effect
by: Catarina Távora, et al.
Published: (2023-10-01) -
Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review
by: Gian Marco Podda, et al.
Published: (2022-01-01)